The Annex to Implementing Regulation (EU) 2015/408 is amended as follows:
(1)
the name ‘carbetamide’ is inserted between the entry ‘carbendazim’ and the entry ‘chlorotoluron’;
(2)
the name ‘emamectin’ is inserted between the entry ‘diquat’ and the entry ‘epoxiconazole’;
(3)
the name ‘flurochloridone’ is inserted between the entry ‘fluquinconazole’ and the entry ‘glufosinate’;
(4)
the name ‘gamma-cyhalothrin’ is inserted between the entry ‘fluquinconazole’ and the entry ‘glufosinate’;
(5)
the name ‘halosulfuron-methyl’ is inserted between the entry ‘glufosinate’ and the entry ‘haloxyfop-P’;
(6)
the name ‘ipconazole’ is inserted between the entry ‘imazosulfuron’ and the entry ‘isoproturon’;
(7)
the name ‘tembotrione’ is inserted between the entry ‘tebufenpyrad’ and the entry ‘tepraloxydim’.